Rating History for Kymera Therapeutics (KYMR) by Canaccord

More Stocks Rated by Canaccord | Latest Ratings for KYMR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/26/2026 Edward Nash Maintain Buy
(N/A)		 129.00
(106.00)		  
 		   Details